HIV resurgence
Epidemiologist Jeff Imai-Eaton warns funding cuts could reverse decades of gains in prevention, care
A series of random questions answered by Harvard experts.
Epidemiologist Jeff Imai-Eaton warns funding cuts could reverse decades of gains in prevention, care
Research highlighting chronic inflammation opens path to treating illness that affects millions of Americans
Study finds most districts already regulate devices. Is the real issue enforcement?
New research shows negative voices are relatively rare in drug approval hearings.
Michael VanRooyen started running toward trouble more than 30 years ago. He’s still going.
long read
Findings suggest colibactin may be promising target for disease prevention
4 min read
Experts weigh in on whether tech poses threat to critical thinking, pointing to cautionary tales in use of other cognitive labor tools
long read